Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 2.760
-0.080 (-2.82%)
Jul 17, 2026, 10:52 AM AEST
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 216.41 million as of July 16, 2026. Its market cap has increased by 126.71% in one year.
Market Cap
216.41M
Enterprise Value
193.95M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.76
ChartMarket Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 216.41M, an increase of 71.18%. That is a compound annual growth rate of 38.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 216.41M | 164.79% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FINEOS Corporation Holdings | 667.28M |
| Tyro Payments | 425.50M |
| Qoria | 328.80M |
| Acusensus | 186.16M |
| Wrkr Ltd | 164.38M |
| Decidr AI Industries | 145.83M |
| EML Payments | 128.26M |
| Adveritas | 75.06M |